Pages that link to "Q40635025"

The following pages link to Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo. (Q40635025):

Displaying 7 items.

• A Src-like inactive conformation in the abl tyrosine kinase domain (Q28469170) (← links)
• Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase (Q33988398) (← links)
• Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib (Q35071103) (← links)
• Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment (Q35663526) (← links)
• Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells (Q36508969) (← links)
• The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib. (Q42805035) (← links)
• Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies (Q46758728) (← links)